Chinese Oncologists was the second largest group at 14th St. Gallen International Breast Cancer Conferences (SG-BCC 2015)

To be exact, 242 Breast Cancer oncologist flied to Vienna, Austria to attend the 14th St. Gallen International Breast Cancer Conferences (SG-BCC 2015), March 18-20, 2015, which made them second only to the oncologist from the hosting country, Switzerland, according to Oncology Frontier(肿瘤瞭望), Beijing, China.

Dr. Binghe Xu, Ph D, Professor, Cancer Hospital, Chinese medical Science Academy, Beijing; Dr. Zefei, Jiang,  Ph D, Professor, 307 Hospital of Chinese People's Liberation Army, Chinese medical Science Academy, Beijing; and Dr. Zhimin Shao, Ph D, Professor, Cancer Hospital, Fudan University, Shanghai were among  the SG-BCC 2015 expert panel, who participated for the St. Gallen Breast Cancer Consensus vote.

From left to right, Dr. Zefei Jiang, Dr. Zhimin Shao, Dr. Binhe Xu after panel vote at SG-BCC 2015
Photo from Ioncol.com

 "My first feeling is that Chinese physicians are more and more influential in the world . St. Gallen Consensus was used to mainly from American and European physicians. It is rare to have 3 physicians in the expert panel from a developing Asian country such as China. This means that China's academic influential power is recognized by international peers. Otherwise we won't be invited," Dr. Binghe Xu stated when he was interviewed by Oncology Frontier.

PS. 438 Hematologists/Oncologists from China attended American Society of Hematology (ASH) annual meeting 2014, San Francisco, was also the second largest group.